Cite
HARVARD Citation
Leiter, L. et al. (n.d.). Dapagliflozin Added to Usual Care in Individuals with Type 2 Diabetes Mellitus with Preexisting Cardiovascular Disease: A 24‐Week, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Study with a 28‐Week Extension. Journal of the American Geriatrics Society. 62 (7), pp. 1252-1262. [Online].